Priced at a premium to peer multiples and intrinsic cash flows, demanding strong execution to justify current levels.
High-quality fundamentals with a strong composite quality score of 82/100, backed by robust profitability and solvency.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: High-quality compounder, with growth as the only relative weakness.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
FAST exhibits elite business quality, driven by exceptional capital efficiency and highly lucrative margins (highlighted by a massive 31.2% ROIC). This is supported by a highly conservative balance sheet featuring strong liquidity and pristine Altman Z safety.
The company demonstrates solid revenue growth (5.5% 3Y CAGR) paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 20.2% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | +8.7% | +5.5% | +7.7% | +7.8% | |
| EBITDA | $384.3M | — | +0.5% | — | — | |
| Net Income | $294.1M | +9.4% | +5.0% | — | +9.3% | |
| EPS (Diluted) | $0.26 | +9.0% | +5.1% | +7.8% | +9.4% | |
| Free Cash Flow | $308.1M | +11.0% | +11.0% | +2.4% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 45.0% | 45.3% | 45.6% | 46.8% |
| Operating Margin | 20.2% | 20.3% | 20.4% | 20.2% |
| Net Margin | 15.3% | 15.4% | 15.5% | 14.8% |
| FCF Margin | 12.8% | 14.2% | 12.7% | 12.0% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.30 | $0.30 | +0.4% | ||
| Q1'26 | $0.26 | $0.26 | +0.3% | ||
| Q4'25 | $0.30 | $0.29 | -2.4% | ||
| Q3'25 | $0.28 | $0.29 | +2.7% | ||
| Q2'25 | $0.26 | $0.26 | +0.0% | ||
| Q1'25 | $0.48 | $0.23 | -52.1% | ||
| Q4'24 | $0.51 | $0.26 | -49.3% | ||
| Q3'24 | $0.51 | $0.25 | -50.9% |
Total return is +12.8% (1Y), lagging the benchmark by -12.2%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +14.7% | +5.4% | — |
| 1Y | +12.8% | -12.2% | +2.2% |
| 3YCAGR | +19.6% | -0.8% | +9.4% |
| 5YCAGR | +14.5% | +1.7% | +15.5% |
| 10YCAGR | +16.6% | +2.8% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Fastenal Company (FAST) valuation, health, and returns.
Fastenal Company is estimated to be overvalued under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. overvalued (implying -37.7% downside from DCF intrinsic value of $28.60)
Fastenal Company has multiple valuation anchors: DCF Intrinsic Value: $28.60 | Peer Relative Fair Value: $33.01 | Wall Street Analyst Target: $46.14 (implying +0.5% upside). A convergence of these signals offers higher conviction.
Fastenal Company displays excellent financial health with a composite quality score of 82/100, supported by a Altman Z-Score of 32.8 (safe zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 31.2%.
Fastenal Company pays a 1.9% dividend yield, covered by a 80% payout ratio with 27 years of growth, supplemented by a 0.0% buyback yield.
Fastenal Company's current growth trajectory is Accelerating. The company achieved +8.7% 1Y revenue growth and +9.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +5.5%.
Wall Street consensus is Hold based on 31 analysts, beating EPS expectations in 50% of recent quarters with a 2-quarter streak. The consensus price target represents a +0.5% change from current levels.
Investment risks for Fastenal Company include: -22.3% 1-year max drawdown. Volatility risk is characterized by a beta of 0.58x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.